Yunfei Zhou, Ph.D. - Publications

Affiliations: 
2005 State University of New York, Buffalo, Buffalo, NY, United States 
Area:
Cell Biology, Oncology

25 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Zhang J, Li X, Zhou Y, Lin M, Zhang Q, Wang Y. FNBP1 Facilitates Cervical Cancer Cell Survival by the Constitutive Activation of FAK/PI3K/AKT/mTOR Signaling. Cells. 12. PMID 37566043 DOI: 10.3390/cells12151964  0.32
2018 Xiao W, Li B, Sun X, Yu D, Xie Y, Wu H, Chang S, Zhou Y, Wang H, Lan X, Xu Z, Shi J, Zhu W. DCZ3301, a novel aryl-guanidino inhibitor, induces cell apoptosis and cell cycle arrest via suppressing the PI3K/AKT pathway in T-cell leukemia/lymphoma. Acta Biochimica Et Biophysica Sinica. PMID 29688264 DOI: 10.1093/abbs/gmy047  0.334
2017 Gao M, Li B, Sun X, Zhou Y, Wang Y, Tompkins VS, Xu Z, Indima N, Wang H, Xiao W, Gao L, Chen G, Wu H, Wu X, Kong Y, et al. Preclinical activity of DCZ3301, a novel aryl-guanidino compound in the therapy of multiple myeloma. Theranostics. 7: 3690-3699. PMID 29109769 DOI: 10.7150/Thno.18345  0.327
2014 Zhou Y, Wan G, Spizzo R, Ivan C, Mathur R, Hu X, Ye X, Lu J, Fan F, Xia L, Calin GA, Ellis LM, Lu X. miR-203 induces oxaliplatin resistance in colorectal cancer cells by negatively regulating ATM kinase. Molecular Oncology. 8: 83-92. PMID 24145123 DOI: 10.1016/J.Molonc.2013.09.004  0.307
2013 Zhou Y, Bollu LR, Tozzi F, Ye X, Bhattacharya R, Gao G, Dupre E, Xia L, Lu J, Fan F, Bellister S, Ellis LM, Weihua Z. ATP citrate lyase mediates resistance of colorectal cancer cells to SN38. Molecular Cancer Therapeutics. 12: 2782-91. PMID 24132143 DOI: 10.1158/1535-7163.Mct-13-0098  0.441
2013 Lu J, Ye X, Fan F, Xia L, Bhattacharya R, Bellister S, Tozzi F, Sceusi E, Zhou Y, Tachibana I, Maru DM, Hawke DH, Rak J, Mani SA, Zweidler-McKay P, et al. Endothelial cells promote the colorectal cancer stem cell phenotype through a soluble form of Jagged-1. Cancer Cell. 23: 171-85. PMID 23375636 DOI: 10.1016/J.Ccr.2012.12.021  0.436
2013 Bellister SA, Fan F, Tozzi F, Lu J, Xia L, Zhou Y, Bhattacharya R, Ye X, Ellis LM. The requirement for freshly isolated human tumor cells for the study of colorectal cancer stem cells. Journal of Clinical Oncology. 31: 411-411. DOI: 10.1200/Jco.2013.31.4_Suppl.411  0.422
2012 Fan F, Samuel S, Evans KW, Lu J, Xia L, Zhou Y, Sceusi E, Tozzi F, Ye XC, Mani SA, Ellis LM. Overexpression of snail induces epithelial-mesenchymal transition and a cancer stem cell-like phenotype in human colorectal cancer cells. Cancer Medicine. 1: 5-16. PMID 23342249 DOI: 10.1002/Cam4.4  0.447
2012 Zhou Y, Tozzi F, Chen J, Fan F, Xia L, Wang J, Gao G, Zhang A, Xia X, Brasher H, Widger W, Ellis LM, Weihua Z. Intracellular ATP levels are a pivotal determinant of chemoresistance in colon cancer cells. Cancer Research. 72: 304-14. PMID 22084398 DOI: 10.1158/0008-5472.Can-11-1674  0.391
2012 Zhou Y, Tozzi F, Xia L, Fan F, Lu J, Maxwell D, Gao G, Bornmann W, Weihua Z, Ellis LM. Abstract B64: Development of a novel strategy to overcome drug resistance by targeting ATP citrate lyase and de novo lipogenesis in colorectal cancer cells Clinical Cancer Research. 18: B64-B64. DOI: 10.1158/1078-0432.Mechres-B64  0.443
2011 Tozzi F, Zhou Y, Chen J, Bose D, Fan F, Wang J, Brusher H, Widger W, Weihua Z, Ellis LM. Evaluation of glycolytic activity and HIF-1α expression in chemoresistant colorectal cancer cells. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 415. PMID 27985808 DOI: 10.1200/Jco.2011.29.4_Suppl.415  0.385
2011 Gaur P, Sceusi EL, Samuel S, Xia L, Fan F, Zhou Y, Lu J, Tozzi F, Lopez-Berestein G, Vivas-Mejia P, Rashid A, Fleming JB, Abdalla EK, Curley SA, Vauthey JN, et al. Identification of cancer stem cells in human gastrointestinal carcinoid and neuroendocrine tumors. Gastroenterology. 141: 1728-37. PMID 21806944 DOI: 10.1053/J.Gastro.2011.07.037  0.435
2011 Zhou Y, Zhou Y, Shingu T, Feng L, Chen Z, Ogasawara M, Keating MJ, Kondo S, Huang P. Metabolic alterations in highly tumorigenic glioblastoma cells: preference for hypoxia and high dependency on glycolysis. The Journal of Biological Chemistry. 286: 32843-53. PMID 21795717 DOI: 10.1074/jbc.M111.260935  0.327
2011 Eric S, Rashid A, Zhou Y, Samuel S, Fan F, Xia L, Ye X, Jia L, Tozzi F, Puja G, Jason F, Eddie A, Curley S, Vauthey J, Zweidler-McKay P, et al. Abstract 5199: Primary culture of human midgut carcinoid cell lines and isolation of a putative carcinoid stem cell population Cancer Research. 71: 5199-5199. DOI: 10.1158/1538-7445.Am2011-5199  0.42
2011 Ye X, Samuel S, Zhou Y, Fan F, Xia L, Lu J, Sceusi E, Tozzi F, Ellis LM. Abstract 5132: Hypo-glycosylation of vascular endothelial growth factor receptor-1 may contribute to intracrine signaling in human colorectal cancer cells Cancer Research. 71: 5132-5132. DOI: 10.1158/1538-7445.Am2011-5132  0.435
2011 Tozzi F, Zhou Y, Chen J, Bose D, Fan F, Xia L, Wang J, Brusher H, Widger W, Ellis LM, Waihua Z. Abstract 4075: Chemoresistant colorectal cancer cells exhibit high glycolytic activity Cancer Research. 71: 4075-4075. DOI: 10.1158/1538-7445.Am2011-4075  0.407
2010 Eric SL, Rashid A, Zhou Y, Samuel S, Fan F, Xia L, Ye X, Lu J, Tozzi F, Gaur P, Yao J, Meyn R, Ellis LM. Abstract 4106: Methods for the development of carcinoid cell lines and carcinoid associated fibroblasts Cancer Research. 70: 4106-4106. DOI: 10.1158/1538-7445.Am10-4106  0.442
2010 Samuel S, Fan F, Dang LH, Gaur P, Xia L, Zhou Y, Liu J, Tozzi F, Sceusi E, Ye X, Ellis LM. Abstract 365: Autocrine vascular endothelial growth factor signaling mediates survival and chemoresistance of human colorectal cancer cells Cancer Research. 70: 365-365. DOI: 10.1158/1538-7445.Am10-365  0.442
2010 Fan F, Evans KW, Mani SA, Zhou Y, Samuel S, Lu J, Xia L, Sceusi E, Tozzi F, Ye X, Ellis LM. Abstract 2300: Overexpression of Snail induces epithelial-mesenchymal transition and cancer stem cell-like phenotypes in CRC cells Cancer Research. 70: 2300-2300. DOI: 10.1158/1538-7445.Am10-2300  0.449
2010 Lu J, Bose D, Zhou Y, Gaur P, Samuel S, Fan F, Xia L, Ye X, Sceusi E, Tozzi F, Mani SA, Ellis LM. Abstract 1281: Endothelial cells promote the cancer stem cell phenotype of human colorectal cancer cells Cancer Research. 70: 1281-1281. DOI: 10.1158/1538-7445.Am10-1281  0.442
2009 Gaur P, Bielenberg DR, Samuel S, Bose D, Zhou Y, Gray MJ, Dallas NA, Fan F, Xia L, Lu J, Ellis LM. Role of class 3 semaphorins and their receptors in tumor growth and angiogenesis. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 6763-70. PMID 19887479 DOI: 10.1158/1078-0432.Ccr-09-1810  0.337
2007 Wang J, Kuropatwinski K, Hauser J, Rossi MR, Zhou Y, Conway A, Kan JL, Gibson NW, Willson JK, Cowell JK, Brattain MG. Colon carcinoma cells harboring PIK3CA mutations display resistance to growth factor deprivation induced apoptosis. Molecular Cancer Therapeutics. 6: 1143-50. PMID 17363507 DOI: 10.1158/1535-7163.Mct-06-0555  0.563
2007 Li S, Zhou Y, Wang R, Zhang H, Dong Y, Ip C. Selenium sensitizes MCF-7 breast cancer cells to doxorubicin-induced apoptosis through modulation of phospho-Akt and its downstream substrates. Molecular Cancer Therapeutics. 6: 1031-8. PMID 17339365 DOI: 10.1158/1535-7163.MCT-06-0643  0.528
2006 Zhou Y, Li S, Hu YP, Wang J, Hauser J, Conway AN, Vinci MA, Humphrey L, Zborowska E, Willson JK, Brattain MG. Blockade of EGFR and ErbB2 by the novel dual EGFR and ErbB2 tyrosine kinase inhibitor GW572016 sensitizes human colon carcinoma GEO cells to apoptosis. Cancer Research. 66: 404-11. PMID 16397255 DOI: 10.1158/0008-5472.Can-05-2506  0.553
2005 Zhou Y, Brattain MG. Synergy of epidermal growth factor receptor kinase inhibitor AG1478 and ErbB2 kinase inhibitor AG879 in human colon carcinoma cells is associated with induction of apoptosis. Cancer Research. 65: 5848-56. PMID 15994962 DOI: 10.1158/0008-5472.Can-04-3509  0.571
Show low-probability matches.